PROXY CORNER: Eli Lilly and Co.

 IBJ Staff
March 20, 2010
Back to TopCommentsE-mailPrintBookmark and Share
Proxy Corner

Eli Lilly and Co., Lilly Corporate Center, Indianapolis, 46285 (www.lilly.com) discovers, develops, manufactures and sells pharmaceutical products for humans and animals. For the quarter ended Dec. 31, 2009, the company reported net income of $915.4 million, or 83 cents per diluted share, on $5.9 billion in revenue. That compares with a net loss of $3.6 billion, or $3.31 per diluted share, on $5.2 billion in revenue in the same period a year ago. The company’s shares trade on the New York Stock Exchange under the ticker symbol LLY. Information for Proxy Corner was taken from Bloomberg News and from the company’s proxy statement dated March 8, 2010.

View full Proxy Corner feature


Post a comment to this story

We reserve the right to remove any post that we feel is obscene, profane, vulgar, racist, sexually explicit, abusive, or hateful.
You are legally responsible for what you post and your anonymity is not guaranteed.
Posts that insult, defame, threaten, harass or abuse other readers or people mentioned in IBJ editorial content are also subject to removal. Please respect the privacy of individuals and refrain from posting personal information.
No solicitations, spamming or advertisements are allowed. Readers may post links to other informational websites that are relevant to the topic at hand, but please do not link to objectionable material.
We may remove messages that are unrelated to the topic, encourage illegal activity, use all capital letters or are unreadable.

Messages that are flagged by readers as objectionable will be reviewed and may or may not be removed. Please do not flag a post simply because you disagree with it.

Sponsored by

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
Subscribe to IBJ